{"id":10206,"date":"2022-06-23T12:06:02","date_gmt":"2022-06-23T12:06:02","guid":{"rendered":"https:\/\/ifpma.flywheelsites.com\/?post_type=publications&#038;p=10206"},"modified":"2023-06-28T17:12:43","modified_gmt":"2023-06-28T15:12:43","slug":"regulatory-agilities-and-regulatory-processes","status":"publish","type":"publications","link":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/","title":{"rendered":"Regulatory agilities and regulatory processes"},"content":{"rendered":"<p class=\"intro\">During the pandemic, agilities in regulatory processes have been key to allowing safe and effective COVID-19 and non-COVID-19 related medicines and vaccines to be rapidly developed, assessed, approved, and accessed.<\/p>\n<p>Extraordinary measures have been applied by National Regulatory Authorities<br \/>\n(NRAs) and the pharmaceutical industry to face the challenges brought by the COVID19 pandemic emergency. A variety of agilities in regulatory processes have been key to allow the rapid development, assessment, approval of and access to safe and effective COVID-19 and non-COVID-19 related medicines and vaccines.<\/p>\n<p>This policy briefing summarizes trends in reported experiences (from primary and<br \/>\nsecondary research) in the use of these agilities observed since the start of the<br \/>\npandemic, some reported challenges to their implementation and forward-looking<br \/>\nrecommendations, whether to prepare for the next pandemic or to strengthen<br \/>\nstandard normative processes to accelerate patient access to safe and effective<br \/>\nmedicines and vaccines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This policy briefing summarizes trends in reported experiences (from primary and<br \/>\nsecondary research) in the use of these agilities observed since the start of the<br \/>\npandemic, some reported challenges to their implementation and forward-looking<br \/>\nrecommendations, whether to prepare for the next pandemic or to strengthen<br \/>\nstandard normative processes to accelerate patient access to safe and effective<br \/>\nmedicines and vaccines.<\/p>\n","protected":false},"featured_media":10232,"template":"","publication_type":[7],"topic":[21,26],"class_list":["post-10206","publications","type-publications","status-publish","has-post-thumbnail","hentry","publication_type-position-paper","topic-covid-19","topic-regulatory-convergence-and-reliance"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Regulatory agilities and regulatory processes | IFPMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regulatory agilities and regulatory processes | IFPMA\" \/>\n<meta property=\"og:description\" content=\"This policy briefing summarizes trends in reported experiences (from primary and secondary research) in the use of these agilities observed since the start of the pandemic, some reported challenges to their implementation and forward-looking recommendations, whether to prepare for the next pandemic or to strengthen standard normative processes to accelerate patient access to safe and effective medicines and vaccines.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/\" \/>\n<meta property=\"og:site_name\" content=\"IFPMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IFPMA\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-28T15:12:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"634\" \/>\n\t<meta property=\"og:image:height\" content=\"896\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@IFPMA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/\",\"url\":\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/\",\"name\":\"Regulatory agilities and regulatory processes | IFPMA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ifpma.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg\",\"datePublished\":\"2022-06-23T12:06:02+00:00\",\"dateModified\":\"2023-06-28T15:12:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#primaryimage\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg\",\"width\":634,\"height\":896},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ifpma.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\/\/www.ifpma.org\/publications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Regulatory agilities and regulatory processes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ifpma.org\/#website\",\"url\":\"https:\/\/www.ifpma.org\/\",\"name\":\"IFPMA\",\"description\":\"Innovating to improve health worldwide\",\"publisher\":{\"@id\":\"https:\/\/www.ifpma.org\/#organization\"},\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ifpma.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ifpma.org\/#organization\",\"name\":\"IFPMA\",\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"url\":\"https:\/\/www.ifpma.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"width\":1379,\"height\":733,\"caption\":\"IFPMA\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/IFPMA\/\",\"https:\/\/x.com\/IFPMA\",\"https:\/\/www.linkedin.com\/company\/ifpma\/\",\"https:\/\/www.youtube.com\/user\/ifpma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulatory agilities and regulatory processes | IFPMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/","og_locale":"en_US","og_type":"article","og_title":"Regulatory agilities and regulatory processes | IFPMA","og_description":"This policy briefing summarizes trends in reported experiences (from primary and secondary research) in the use of these agilities observed since the start of the pandemic, some reported challenges to their implementation and forward-looking recommendations, whether to prepare for the next pandemic or to strengthen standard normative processes to accelerate patient access to safe and effective medicines and vaccines.","og_url":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/","og_site_name":"IFPMA","article_publisher":"https:\/\/www.facebook.com\/IFPMA\/","article_modified_time":"2023-06-28T15:12:43+00:00","og_image":[{"width":634,"height":896,"url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@IFPMA","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/","url":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/","name":"Regulatory agilities and regulatory processes | IFPMA","isPartOf":{"@id":"https:\/\/www.ifpma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#primaryimage"},"image":{"@id":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg","datePublished":"2022-06-23T12:06:02+00:00","dateModified":"2023-06-28T15:12:43+00:00","breadcrumb":{"@id":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#primaryimage","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/06\/report_220623_regulatory-processes.jpg","width":634,"height":896},{"@type":"BreadcrumbList","@id":"https:\/\/www.ifpma.org\/publications\/regulatory-agilities-and-regulatory-processes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ifpma.org\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/www.ifpma.org\/publications\/"},{"@type":"ListItem","position":3,"name":"Regulatory agilities and regulatory processes"}]},{"@type":"WebSite","@id":"https:\/\/www.ifpma.org\/#website","url":"https:\/\/www.ifpma.org\/","name":"IFPMA","description":"Innovating to improve health worldwide","publisher":{"@id":"https:\/\/www.ifpma.org\/#organization"},"alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ifpma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ifpma.org\/#organization","name":"IFPMA","alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","url":"https:\/\/www.ifpma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","width":1379,"height":733,"caption":"IFPMA"},"image":{"@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IFPMA\/","https:\/\/x.com\/IFPMA","https:\/\/www.linkedin.com\/company\/ifpma\/","https:\/\/www.youtube.com\/user\/ifpma"]}]}},"_links":{"self":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publications\/10206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publications"}],"about":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/types\/publications"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media\/10232"}],"wp:attachment":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media?parent=10206"}],"wp:term":[{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publication_type?post=10206"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/topic?post=10206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}